Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


1 Am J Med
1 Antiviral Res
1 Arch Virol
1 BMC Pediatr
1 Epidemiol Infect
1 J Immunol
1 J Infect
3 J Virol
6 J Virol Methods
4 Lancet
2 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatrics
2 PLoS Comput Biol
32 PLoS One
2 Proc Natl Acad Sci U S A
14 Vaccine
2 Virology
6 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. HAMMOND MM, Cameron NA, Shah NS, Khan SS, et al
    An Age-Period-Cohort Analysis of Cardiovascular Disease Mortality in the United States from 1999 to 2018.
    Am J Med. 2024 Feb 22:S0002-9343(24)00108-6. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

    Antiviral Res

  2. FRANCO-MAY DA, Gomez-Carballo J, Barrera-Badillo G, Cruz-Ortiz MN, et al
    Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.
    Antiviral Res. 2024;227:105918.
    PubMed         Abstract available

    Arch Virol

  3. HE L, Cao J, Xie X, Zhang Y, et al
    Effects and mechanism of Qingke Pingchuan granules against influenza virus infection.
    Arch Virol. 2024;169:130.
    PubMed         Abstract available

    BMC Pediatr

  4. AL-KUWARI MG, Mohammed AM, Abdulmajeed J, Al-Romaihi H, et al
    COVID-19 testing, incidence, and positivity trends among school age children during the academic years 2020-2022 in the State of Qatar: special focus on using CDC indicators for community transmission to evaluate school attendance policies and public
    BMC Pediatr. 2024;24:374.
    PubMed         Abstract available


  5. REYNOLDS C, Naqvi H
    Better use of data can help to prevent future deaths.
    BMJ. 2024;385:q1181.

  6. LYNN E
    May top picks: politics, psychological safety, and creativity.
    BMJ. 2024;385:q1166.

    Pandemic treaty: panel calls for "reset" to talks as negotiators miss deadline.
    BMJ. 2024;385:q1193.

  8. LIMB M
    Labour's pledge to clear NHS waiting list within five years will be tough to achieve, say leaders.
    BMJ. 2024;385:q1186.

    Junior doctors in England announce five day walkout ahead of general election.
    BMJ. 2024;385:q1183.

  10. MAHASE E
    GPs could threaten mass resignation over NHS contract.
    BMJ. 2024;385:q1182.

  11. WISE J
    Improving infection prevention could avoid 750 000 deaths a year, say experts.
    BMJ. 2024;385:q1163.

  12. DYER O
    Covid-19: South African disclosures reveal secretive world of nations' vaccine contracts.
    BMJ. 2024;385:q1172.

    Epidemiol Infect

  13. YI B, Patrasova E, Simunkova L, Rost F, et al
    Investigating the cause of a 2021 winter wave of COVID-19 in a border region in eastern Germany: a mixed-methods study, August to November 2021.
    Epidemiol Infect. 2024;152:e87.
    PubMed         Abstract available

    J Immunol

  14. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    PubMed         Abstract available

    J Infect

  15. SKAARUP KG, Lassen MCH, Modin D, Johansen ND, et al
    The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials.
    J Infect. 2024;89:106187.
    PubMed         Abstract available

    J Virol

  16. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.

  17. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.

  18. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.

    J Virol Methods

  19. MAK WA, Visser W, Koeleman JGM, Ong DSY, et al
    SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
    J Virol Methods. 2024;327:114949.
    PubMed         Abstract available

  20. HAMILTON S, Zhu M, Cloney-Clark S, Mayes P, et al
    Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
    J Virol Methods. 2024;327:114945.
    PubMed         Abstract available

  21. EDWARDS K, Corocher T, Hersusianto Y, Campbell D, et al
    Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.
    J Virol Methods. 2024;327:114944.
    PubMed         Abstract available

  22. VASQUEZ V, Orozco J
    Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex.
    J Virol Methods. 2024;327:114940.
    PubMed         Abstract available

  23. DOSBAA A, Guilbaud R, Yusti AF, Ferre VM, et al
    RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis.
    J Virol Methods. 2024;327:114938.
    PubMed         Abstract available

  24. OUSSET MJ, Pianciola LA, Mazzeo M, Oteiza JM, et al
    Improved SARS-CoV-2 RNA recovery in wastewater matrices using a CTAB-based extraction method.
    J Virol Methods. 2024;327:114918.
    PubMed         Abstract available


  25. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.

  26. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.


    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.

    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.

  29. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.

    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.

    MMWR Morb Mortal Wkly Rep

  31. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.

  32. GARG S, Reed C, Davis CT, Uyeki TM, et al
    Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:501-505.

    N Engl J Med

  33. HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al
    Global Health Law for a Safer and Fairer World.
    N Engl J Med. 2024;390:1925-1931.


  34. DALAPATI T, Williams CA, Giorgi EE, Hurst JH, et al
    Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children Less Than 5 Years of Age.
    Pediatrics. 2024 Mar 29. doi: 10.1542/peds.2024-066190.
    PubMed         Abstract available

  35. GAVIRIA-AGUDELO C, Yonts AB, Kimberlin DW, Campbell JD, et al
    February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines.
    Pediatrics. 2024 Mar 29. doi: 10.1542/peds.2024-066653.
    PubMed         Abstract available

    PLoS Comput Biol

  36. MASSEY A, Boennec C, Restrepo-Ortiz CX, Blanchet C, et al
    Real-time forecasting of COVID-19-related hospital strain in France using a non-Markovian mechanistic model.
    PLoS Comput Biol. 2024;20:e1012124.
    PubMed         Abstract available

  37. FOSTER ZSL, Tupper AS, Press CM, Grunwald NJ, et al
    Krisp: A Python package to aid in the design of CRISPR and amplification-based diagnostic assays from whole genome sequencing data.
    PLoS Comput Biol. 2024;20:e1012139.
    PubMed         Abstract available

    PLoS One

  38. RAKIB MI, Alam MJ, Akter N, Tuhin KH, et al
    Change in hierarchy of the financial networks: A study on firms of an emerging market in Bangladesh.
    PLoS One. 2024;19:e0301725.
    PubMed         Abstract available

  39. KUCZYK C, Munch K, Nohre M, Stephan M, et al
    Development and testing of a questionnaire on the expectations and experiences with wearing face masks in inpatient and day hospitals.
    PLoS One. 2024;19:e0304140.
    PubMed         Abstract available

  40. VOUTOURI C, Hardin CC, Naranbhai V, Nikmaneshi MR, et al
    Dynamic heterogeneity in COVID-19: Insights from a mathematical model.
    PLoS One. 2024;19:e0301780.
    PubMed         Abstract available

  41. ZHANG EY, Baldwin A, Hundley C, Chang E, et al
    Influence of an extreme event-the COVID-19 pandemic-On establishment of and data collection by a citizen science project.
    PLoS One. 2024;19:e0303429.
    PubMed         Abstract available

  42. HUANG W, Ichikohji T
    How dynamic capabilities enable Chinese SMEs to survive and thrive during COVID-19: Exploring the mediating role of business model innovation.
    PLoS One. 2024;19:e0304471.
    PubMed         Abstract available

  43. HABTEMARIAM S, Hery CM, Zhang X, Yu M, et al
    Association between sociodemographics and change in alcohol or tobacco use behaviors during the COVID-19 pandemic.
    PLoS One. 2024;19:e0304111.
    PubMed         Abstract available

  44. CHEN Y, Li H, Lin J, Su Z, et al
    Association between (DeltaPaO2/FiO2)/PEEP and in-hospital mortality in patients with COVID-19 pneumonia: A secondary analysis.
    PLoS One. 2024;19:e0304518.
    PubMed         Abstract available

  45. ABDUL-MUMIN A, Bimpong KA, Cotache-Condor C, Oppong J, et al
    Impact of the COVID-19 pandemic on perinatal care and outcomes: A retrospective study in a tertiary hospital in Northern Ghana.
    PLoS One. 2024;19:e0301081.
    PubMed         Abstract available

  46. LIU N, Li Y, Jiang M, Liu B, et al
    Trade shocks and trade diversion due to epidemic diseases: Evidence from 110 countries.
    PLoS One. 2024;19:e0301828.
    PubMed         Abstract available

  47. TAO W, Zhou JY
    A study on the "Porter Hypothesis" effect of the regulatory measures of the environmental protection tax law in the post-pandemic era.
    PLoS One. 2024;19:e0304636.
    PubMed         Abstract available

  48. RAK A, Matyushenko V, Prokopenko P, Kostromitina A, et al
    A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
    PLoS One. 2024;19:e0304534.
    PubMed         Abstract available

  49. NGOMTCHO SCH, Akenji BM, Tchio-Nighie KH, Fokam J, et al
    SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
    PLoS One. 2024;19:e0304477.
    PubMed         Abstract available

  50. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    PubMed         Abstract available

  51. WELLSPRING I, Ganesh K, Kreklewetz K
    Walk-in mental health: Bridging barriers in a pandemic.
    PLoS One. 2024;19:e0302543.
    PubMed         Abstract available

  52. ELGEDAWY GA, Samir M, Elabd NS, Elsaid HH, et al
    Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learning.
    PLoS One. 2024;19:e0302977.
    PubMed         Abstract available

  53. CAO D, Tahir SH, Rizvi SMR, Khan KB, et al
    Exploring the influence of women's leadership and corporate governance on operational liquidity: The glass cliff effect.
    PLoS One. 2024;19:e0302210.
    PubMed         Abstract available

  54. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of person-centred active rehabilitation on symptoms of suspected Chronic Traumatic Encephalopathy: A mixed-methods single case design.
    PLoS One. 2024;19:e0302260.
    PubMed         Abstract available

  55. RAHMAN A, Russell M, Zheng W, Eckrich D, et al
    SARS-CoV-2 infection is associated with an increase in new diagnoses of schizophrenia spectrum and psychotic disorder: A study using the US national COVID cohort collaborative (N3C).
    PLoS One. 2024;19:e0295891.
    PubMed         Abstract available

  56. KIMANI ME, Sarr M
    Association of race/ethnicity and severe housing problems with COVID-19 deaths in the United States: Analysis of the first three waves.
    PLoS One. 2024;19:e0303667.
    PubMed         Abstract available

  57. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    PubMed         Abstract available

  58. YOUSEF CC, Farooq A, Amateau G, Abu Esba LC, et al
    The effect of job and personal demands and resources on healthcare workers' wellbeing: A cross-sectional study.
    PLoS One. 2024;19:e0303769.
    PubMed         Abstract available

  59. DASARI H, Smyrnova A, Leng J, Ducharme FM, et al
    Feasibility, acceptability, and safety of a novel device for self-collecting capillary blood samples in clinical trials in the context of the pandemic and beyond.
    PLoS One. 2024;19:e0304155.
    PubMed         Abstract available

  60. BREBAN R
    Emergence failure of early epidemics: A mathematical modeling approach.
    PLoS One. 2024;19:e0301415.
    PubMed         Abstract available

  61. ACHEAMPONG E, Husain AA, Dudani H, Nayak AR, et al
    Population infection estimation from wastewater surveillance for SARS-CoV-2 in Nagpur, India during the second pandemic wave.
    PLoS One. 2024;19:e0303529.
    PubMed         Abstract available

  62. PASQUALE DK, Welsh W, Bentley-Edwards KL, Olson A, et al
    Homophily and social mixing in a small community: Implications for infectious disease transmission.
    PLoS One. 2024;19:e0303677.
    PubMed         Abstract available

  63. KEMPTHORNE J, Yogeeswaran K, Sibley CG, Bulbulia JA, et al
    The anatomy of prejudice during pandemic lockdowns: Evidence from a national panel study.
    PLoS One. 2024;19:e0303845.
    PubMed         Abstract available

  64. KLEINAU E, Lamba T, Jaskiewicz W, Gorentz K, et al
    Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial.
    PLoS One. 2024;19:e0303370.
    PubMed         Abstract available

  65. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    PubMed         Abstract available

  66. ZHAO Y, Liu F, Lin P, Tu Z, et al
    Sleep quality and mental health among Chinese nurses after the COVID-19 pandemic: A moderated model.
    PLoS One. 2024;19:e0295105.
    PubMed         Abstract available

  67. SIMANDJUNTAK DP, Jaenicke EC, Wrenn DH
    Pandemic-induced changes in household-level food diversity and diet quality in the U.S.
    PLoS One. 2024;19:e0300839.
    PubMed         Abstract available

  68. SALMAN M, Zhu Y, Kiran S, Sibt E Ali M, et al
    Corporate social responsibility: A key driver of sustainable development in China's post-COVID economy.
    PLoS One. 2024;19:e0300209.
    PubMed         Abstract available

  69. BALAMPAMA M, de Walque D, Dow WH, Hemono R, et al
    Influence of COVID-19 on female sex workers in Dar es Salaam, Tanzania: A mixed-methods analysis.
    PLoS One. 2024;19:e0303993.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  70. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
    Biophysical principles predict fitness of SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2024;121:e2314518121.
    PubMed         Abstract available

  71. QU B, Miskey C, Gomer A, Kleinert RDV, et al
    TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Proc Natl Acad Sci U S A. 2024;121:e2407437121.
    PubMed         Abstract available


  72. ADINUGROHO I, Stafford T, Bentall RP
    The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Vaccine. 2024 May 3:S0264-410X(24)00510-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  73. CHRISTOU-ERGOS M, Bleicher K, Leask J
    Factors associated with vaccination intention and uptake over time in a sample of older Australians.
    Vaccine. 2024 May 3:S0264-410X(24)00508-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  74. BAGLIVO F, De Angelis L, Magri M, De Nicola I, et al
    The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents' attitudes towards mandatory and recommended vaccination in Southern Italy.
    Vaccine. 2024 May 3:S0264-410X(24)00513-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  75. MARINTHE G, Brown G, Cristea M, Kutlaca M, et al
    Predicting vaccination hesitancy: The role of basic needs satisfaction and institutional trust.
    Vaccine. 2024 May 3:S0264-410X(24)00507-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  76. DORJEE K, Namdon T, Topgyal S, Gyatso U, et al
    Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
    Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  77. XIE Z, Stallings-Smith S, Patel S, Case S, et al
    COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population.
    Vaccine. 2024 Apr 25:S0264-410X(24)00509-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  78. BAK J, Hasan Q, Kissa J, Mere MO, et al
    Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021-23: How do we switch to a life course approach?
    Vaccine. 2024 May 24:S0264-410X(24)00560-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  79. DINH THIEM V, Van Anh PT, Van Men C, Hung DT, et al
    A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial.
    Vaccine. 2024 May 10:S0264-410X(24)00523-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  80. MALTEZOU HC, Gamaletsou MN, Giannouchos TV, Koukou DM, et al
    Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants.
    Vaccine. 2024 May 9:S0264-410X(24)00522-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  81. CAO A, Ueta M, Uchibori M, Murakami M, et al
    Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan.
    Vaccine. 2024 May 6:S0264-410X(24)00520-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  82. JEARANAIWITAYAKUL T, Sunintaboon P, Kittiayuwat A, Limthongkul J, et al
    Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
    Vaccine. 2024 May 6:S0264-410X(24)00519-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  83. KUMRU OS, Sanyal M, Friedland N, Hickey JM, et al
    Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines.
    Vaccine. 2023 Aug 22:S0264-410X(23)00969-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  84. CARDENAS V, Le Gars M, Truyers C, Ruiz-Guinazu J, et al
    Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
    Vaccine. 2024;42:3536-3546.
    PubMed         Abstract available

  85. MARANTOS T, Kyriazopoulou E, Angelakis E, Kitsos D, et al
    Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center prospective study.
    Vaccine. 2024 May 24:S0264-410X(24)00617-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


  86. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed         Abstract available

  87. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed         Abstract available

    Virus Res

  88. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed         Abstract available

  89. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed         Abstract available

  90. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed         Abstract available

  91. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed         Abstract available

  92. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed         Abstract available

  93. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.